ARTICLE | Management Tracks
Wessman to be CEO at Alvotech
Plus: Sabus goes to Syndax and updates from SciNeuro, Sapience and BillionToOne
December 2, 2022 9:30 PM UTC
Alvotech Holdings S.A. (NASDAQ:ALVO) named Robert Wessman as CEO effective Jan. 1, 2023. Wessman, who founded Alvotech, will succeed Mark Levick, who has decided to retire. Hafrun Fridriksdottir, former EVP and head of global R&D at Teva Pharmaceutical Industries Ltd. (NYSE:TEVA; Tel Aviv:TEVA), will take over as COO on the same date.
Oncology company Syndax Pharmaceuticals Inc. (NASDAQ:SNDX) hired Steve Sabus as chief commercial officer (CCO), effective Dec. 5. Sabus was CCO at Turning Point Therapeutics Inc., and held several senior commercial roles at Astellas Pharma Inc. (Tokyo:4503) for over 15 years...